Clinical trial
Retrospective Observational Study on Clinical Outcomes and Treatment Management of First-Line Systemic Therapies in Patients With Advanced Renal Cell Carcinoma in Spain Using the BIG-PAC® Database
NCT07852884 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Observational Study on Clinical Outcomes and Treatment Management of First-Line Systemic Therapies in Patients With Advanced Renal Cell Carcinoma in Spain Using the BIG-PAC® Database
- Lead sponsor
- Bristol-Myers Squibb
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 15, 2026
- Completion date
- December 1, 2026
- Enrollment
- 1,200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal cell carcinoma (rcc)